Trial intelligence / Profile preview

Efficacy of itraconazole in the prevention of recurrence of Pityriasis Versicolor

IRCT20210823052264N8Phase 3Completed

Sponsor
Combined Military Hospital Quetta
Start
Aug 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of itraconazole in pityriasis versicolor, sponsored by Combined Military Hospital Quetta. Started Aug 2024; status: completed.

02

Drugs

itraconazole
03

Conditions

pityriasis versicolor

Beyond the preview

Go deeper on IRCT20210823052264N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210823052264N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call